LYZL6

gene
On this page

Also known as LYC1PRO1485TKAL754

Summary

LYZL6 (lysozyme like 6, HGNC:29614) is a protein-coding gene on chromosome 17q12, encoding Lysozyme-like protein 6 (O75951). May be involved sperm-egg plasma membrane adhesion and fusion during fertilization.

This gene encodes a member of the C-type lysozyme/alpha-lactalbumin family. C-type lysozymes are bacteriolytic factors that play a role in host defense, whereas alpha-lactalbumins mediate lactose biosynthesis. The encoded protein contains catalytic residues characteristic of C-type lysozymes and may play a role in male reproduction. Alternatively spliced transcript variants have been observed for this gene.

Source: NCBI Gene 57151 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 24 total
  • MANE Select transcript: NM_020426

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29614
Approved symbolLYZL6
Namelysozyme like 6
Location17q12
Locus typegene with protein product
StatusApproved
AliasesLYC1, PRO1485, TKAL754
Ensembl geneENSG00000275722
Ensembl biotypeprotein_coding
OMIM612751
Entrez57151

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000615905, ENST00000617692, ENST00000618542

RefSeq mRNA: 2 — MANE Select: NM_020426 NM_001199951, NM_020426

CCDS: CCDS11302

Canonical transcript exons

ENST00000615905 — 5 exons

ExonStartEnd
ENSE000037131093593675535936833
ENSE000037198583594356735943713
ENSE000037344373593451835934865
ENSE000037434403593921835939558
ENSE000037484933593775835937916

Expression profiles

Bgee: expression breadth broad, 39 present calls, max score 90.95.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0243 / max 23.0053, expressed in 3 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1654080.01533
1654110.00893

Top tissues by expression

100 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453390.95gold quality
right testisUBERON:000453490.60gold quality
testisUBERON:000047390.55gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.29gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099154.79gold quality
sural nerveUBERON:001548842.59silver quality
granulocyteCL:000009437.94gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
liverUBERON:000210736.16gold quality
ganglionic eminenceUBERON:000402335.49gold quality
right lobe of liverUBERON:000111435.14silver quality
skeletal muscle tissueUBERON:000113433.38gold quality
vermiform appendixUBERON:000115433.33silver quality
bloodUBERON:000017833.23gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
urinary bladderUBERON:000125531.37silver quality
leukocyteCL:000073831.15gold quality
muscle tissueUBERON:000238531.06gold quality
monocyteCL:000057630.84gold quality
stromal cell of endometriumCL:000225529.87gold quality
tonsilUBERON:000237229.07gold quality
prefrontal cortexUBERON:000045129.04gold quality
duodenumUBERON:000211428.14gold quality
descending thoracic aortaUBERON:000234527.59gold quality
lymph nodeUBERON:000002927.57gold quality
right adrenal gland cortexUBERON:003582727.32silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.32

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

28 targeting LYZL6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4283100.0066.422097
HSA-MIR-12118100.0065.881270
HSA-MIR-318599.9968.121959
HSA-MIR-223-3P99.9970.141140
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-431999.7669.832586
HSA-MIR-10393-3P99.7266.56961
HSA-MIR-6801-5P99.7266.50981
HSA-MIR-5004-5P99.6866.631294
HSA-MIR-320299.6667.702737
HSA-MIR-432899.5771.064094
HSA-MIR-671-5P99.5267.111277
HSA-MIR-361299.4566.021333
HSA-MIR-65099.4565.771309
HSA-MIR-125A-5P99.3670.591640
HSA-MIR-125B-5P99.3670.361662
HSA-MIR-3678-3P99.3167.101432
HSA-MIR-10522-5P99.2668.502087
HSA-MIR-4795-5P99.1166.90876
HSA-MIR-6871-5P98.9066.67671
HSA-MIR-950098.6266.541845
HSA-MIR-444398.0266.251928
HSA-MIR-7847-3P96.6364.58952

Literature-anchored findings (GeneRIF, showing 1)

  • LYZL6, an acidic, bacteriolytic and human sperm-related protein, is likely important for fertilization but not for the innate immunity of the male reproductive tract. (PMID:28182716)

Cross-species orthologs

14 orthologs

OrganismSymbolGene ID
mus_musculusLyzl6ENSMUSG00000020945
rattus_norvegicusLyzl6ENSRNOG00000003501
drosophila_melanogasterLysBFBGN0004425
drosophila_melanogasterLysDFBGN0004427
drosophila_melanogasterLysEFBGN0004428
drosophila_melanogasterLysPFBGN0004429
drosophila_melanogasterLysSFBGN0004430
drosophila_melanogasterLysXFBGN0004431
drosophila_melanogasterCG16756FBGN0029765
drosophila_melanogasterCG7798FBGN0034092
drosophila_melanogasterCG16799FBGN0034538
drosophila_melanogasterCG11159FBGN0034539
drosophila_melanogasterCG8492FBGN0035813
drosophila_melanogasterCG30062FBGN0050062

Paralogs (8): LYZ (ENSG00000090382), LYZL1 (ENSG00000120563), SPACA3 (ENSG00000141316), LYZL2 (ENSG00000151033), LYZL4 (ENSG00000157093), LALBA (ENSG00000167531), SPACA5B (ENSG00000171478), SPACA5 (ENSG00000171489)

Protein

Protein identifiers

Lysozyme-like protein 6O75951 (reviewed: O75951)

All UniProt accessions (3): O75951, A0A080YUZ6, A0A087WXX7

UniProt curated annotations — full annotation on UniProt →

Function. May be involved sperm-egg plasma membrane adhesion and fusion during fertilization. Exhibits bacteriolytic activity in vitro against Micrococcus luteus and Staphylococcus aureus. Shows weak bacteriolytic activity against Gram-positive bacteria at physiological pH. Bacteriolytic activity is pH-dependent, with a maximum at around pH 5.6.

Subunit / interactions. Monomer.

Subcellular location. Secreted. Cell surface. Cell projection. Cilium. Flagellum.

Tissue specificity. Expressed in testis, epididymis and spermatozoa (at protein level). Expressed in late-stage spermatocytes and round spermatids.

Similarity. Belongs to the glycosyl hydrolase 22 family.

RefSeq proteins (2): NP_001186880, NP_065159* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000974Glyco_hydro_22_lysFamily
IPR001916Glyco_hydro_22Family
IPR019799Glyco_hydro_22_CSDomain
IPR023346Lysozyme-like_dom_sfHomologous_superfamily

Pfam: PF00062

UniProt features (10 total): disulfide bond 4, active site 2, signal peptide 1, chain 1, domain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75951-F192.840.86

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (2): 54; 71

Disulfide bonds (4): 25–145, 49–133, 83–98, 94–112

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 70 (showing top): GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOCC_CELL_SURFACE, GGGTGGRR_PAX4_03, SHEPARD_BMYB_MORPHOLINO_DN, MODULE_205, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PLASMA_MEMBRANE_FUSION, MORF_PDPK1, GOBP_MEMBRANE_ORGANIZATION, GOBP_FERTILIZATION, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM

GO Biological Process (5): fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342), fertilization (GO:0009566), killing of cells of another organism (GO:0031640), defense response to bacterium (GO:0042742), single fertilization (GO:0007338)

GO Molecular Function (4): lysozyme activity (GO:0003796), catalytic activity (GO:0003824), hydrolase activity (GO:0016787), hydrolase activity, acting on glycosyl bonds (GO:0016798)

GO Cellular Component (9): acrosomal vesicle (GO:0001669), extracellular region (GO:0005576), cell surface (GO:0009986), sperm flagellum (GO:0036126), sperm midpiece (GO:0097225), sperm plasma membrane (GO:0097524), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
single fertilization1
cellular process involved in reproduction in multicellular organism1
sexual reproduction1
reproductive process1
cell killing1
disruption of cell in another organism1
defense response1
response to bacterium1
fertilization1
hydrolase activity, hydrolyzing O-glycosyl compounds1
peptidoglycan muralytic activity1
molecular_function1
catalytic activity1
hydrolase activity1
secretory granule1
9+2 motile cilium1
sperm flagellum1
plasma membrane1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cilium1

Protein interactions and networks

STRING

482 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LYZL6C12orf71A8MTZ7531
LYZL6ASTLQ6HA08479
LYZL6ANKRD27Q96NW4472
LYZL6TEX38Q6PEX7459
LYZL6SCP2D1Q9UJQ7447
LYZL6SPRYD4Q8WW59443
LYZL6SPATA31F1Q6ZU69432
LYZL6PRR30Q53SZ7430
LYZL6CIMIP2AQ6J272422
LYZL6CIMIP4O43247418
LYZL6MEGF8Q7Z7M0384
LYZL6CPMP14384380
LYZL6GARIN1BQ96KD3374
LYZL6YEATS4O95619371
LYZL6MIPP30301370

IntAct

6 interactions, top by confidence:

ABTypeScore
LYZL6COL6A1psi-mi:“MI:0914”(association)0.530
LYZL6reppsi-mi:“MI:0915”(physical association)0.370
ECE1LYZL6psi-mi:“MI:0915”(physical association)0.370
LYZL6PLXNA2psi-mi:“MI:0914”(association)0.350
LYZL6CLGNpsi-mi:“MI:0914”(association)0.350

BioGRID (33): TYW3 (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), POGLUT1 (Affinity Capture-MS), SLC25A30 (Affinity Capture-MS), SLC16A10 (Affinity Capture-MS), PLXNA2 (Affinity Capture-MS), TUBB8 (Affinity Capture-MS), VSIG8 (Affinity Capture-MS), EOGT (Affinity Capture-MS), FKBP14 (Affinity Capture-MS), TMEM2 (Affinity Capture-MS), SEMG1 (Affinity Capture-MS), SEMG2 (Affinity Capture-MS), CTSF (Affinity Capture-MS), ATP12A (Affinity Capture-MS)

ESM2 similar proteins: A2AE20, C0HLB7, C1IIX1, D4ABW7, D9J142, D9J143, G3XDT7, O75951, P00702, P00709, P00710, P00711, P00712, P00713, P00714, P00716, P05105, P07458, P08334, P08896, P09462, P11375, P11376, P12065, P18137, P28546, P29752, P30805, P37161, P48816, P50717, P50718, P51782, P61944, P81646, P81708, P85045, Q06655, Q29145, Q29RT1

Diamond homologs: A0JNM6, A2AE20, A6QQ77, B6VH75, B6VH76, G3XDT7, O75951, P00697, P00698, P00699, P00700, P00701, P00702, P00703, P00704, P00705, P00706, P00707, P00708, P04421, P08905, P11375, P11376, P11941, P12066, P12067, P12068, P12069, P16973, P17607, P17897, P19849, P22910, P24364, P24533, P30201, P37712, P37713, P49663, P61626

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance20
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

739 predictions. Top by Δscore:

VariantEffectΔscore
17:35936685:A:ACdonor_gain1.0000
17:35936685:ACTG:Adonor_gain1.0000
17:35936686:C:CCdonor_gain1.0000
17:35936686:CTGC:Cdonor_gain1.0000
17:35936706:T:TAdonor_gain1.0000
17:35936834:C:CCacceptor_gain1.0000
17:35937916:CCT:Cacceptor_gain1.0000
17:35937918:T:Cacceptor_gain1.0000
17:35936676:T:TAdonor_gain0.9900
17:35936685:ACTGC:Adonor_gain0.9900
17:35936686:CTG:Cdonor_gain0.9900
17:35936686:CTGCC:Cdonor_gain0.9900
17:35936688:G:GAdonor_gain0.9900
17:35936689:C:Adonor_gain0.9900
17:35936709:T:TAdonor_gain0.9900
17:35936748:T:TAdonor_gain0.9900
17:35936831:GAT:Gacceptor_gain0.9900
17:35936833:TC:Tacceptor_loss0.9900
17:35936834:C:CGacceptor_loss0.9900
17:35937915:CCCT:Cacceptor_gain0.9900
17:35936829:CAGAT:Cacceptor_gain0.9800
17:35937792:A:Cdonor_gain0.9800
17:35937912:CAGCC:Cacceptor_gain0.9800
17:35942571:T:Adonor_gain0.9800
17:35937918:T:TCacceptor_gain0.9700
17:35943562:CTTA:Cdonor_loss0.9700
17:35943566:C:CAdonor_loss0.9700
17:35934864:CC:Cacceptor_gain0.9600
17:35934865:CC:Cacceptor_gain0.9600
17:35936786:T:Adonor_gain0.9600

AlphaMissense

982 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:35934856:C:AW129C0.968
17:35934856:C:GW129C0.968
17:35934865:C:AW126C0.968
17:35934865:C:GW126C0.968
17:35937832:A:CF75C0.965
17:35937891:G:CS55R0.956
17:35937891:G:TS55R0.956
17:35937893:T:GS55R0.956
17:35937819:G:CS79R0.949
17:35937819:G:TS79R0.949
17:35937821:T:GS79R0.949
17:35937808:C:GC83S0.946
17:35937809:A:TC83S0.946
17:35937915:C:AW47C0.945
17:35937915:C:GW47C0.945
17:35936790:T:AK114N0.944
17:35936790:T:GK114N0.944
17:35937892:C:AS55I0.939
17:35934820:C:AW141C0.937
17:35934820:C:GW141C0.937
17:35937900:A:CF52L0.934
17:35937900:A:TF52L0.934
17:35937902:A:GF52L0.934
17:35937885:G:CF57L0.933
17:35937885:G:TF57L0.933
17:35937887:A:GF57L0.933
17:35937832:A:GF75S0.927
17:35939240:A:CF39L0.926
17:35939240:A:TF39L0.926
17:35939242:A:GF39L0.926

dbSNP variants (sampled 300 via entrez): RS1000050714 (17:35942353 T>C), RS1000403681 (17:35942653 A>G), RS1000406439 (17:35935331 T>A,C), RS1000796156 (17:35934908 C>G,T), RS1000853683 (17:35939955 G>A), RS1000873860 (17:35941448 T>G), RS1001004427 (17:35941047 C>A,G), RS1001013387 (17:35945559 C>T), RS1001305766 (17:35939639 T>C), RS1001920820 (17:35944426 G>A), RS1002015576 (17:35944110 T>C), RS1002407179 (17:35939460 A>C), RS1002531869 (17:35944123 T>G), RS1002858361 (17:35937228 G>A), RS1002932122 (17:35943231 G>A,C,T)

Disease associations

OMIM: gene MIM:612751 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, affects cotreatment3
entinostatincreases expression, affects cotreatment2
belinostatincreases expression, affects cotreatment2
Panobinostataffects cotreatment, increases expression2
trichostatin Aincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
dorsomorphinaffects cotreatment, increases expression1
Vorinostatincreases expression1
Cyclosporineincreases expression1
Aflatoxin B1increases methylation1
Antirheumatic Agentsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.